Hospital
East Carolina Health - Heritage INC
East Carolina Health - Heritage INC was paid $12.89M by Medicaid between Jan 2018 and Dec 2024, across 108 billing codes. Its largest line is 99284, emergency room visit (serious) — 17% of everything it billed.
33Billing provider infoEAST CAROLINA HEALTH - HERITAGE INC
TARBORO, NC 27886
TARBORO, NC 27886
33aNPI1699757393assigned 11/17/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$12.89M
24GClaims300,086
24DCodes billed108
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in North Carolina
Rank by total paid#43 of 92
Median peer was paid$11.47M
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 45,073 | $1.29M | |
| 2019 | 40,575 | $1.30M | |
| 2020 | 30,574 | $706K | |
| 2021 | 33,204 | $1.44M | |
| 2022 | 33,949 | $2.15M | |
| 2023 | 51,049 | $2.76M | |
| 2024incomplete | 65,662 | $3.25M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 18,057 | 16,997 | $2.18M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 24,135 | 22,861 | $2.03M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 10,058 | 9,448 | $1.40M |
| 0225U | 7.8% | 2,626 | 2,484 | $1.00M | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.6% | 1,223 | 1,123 | $722K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 5.6% | 4,793 | 4,563 | $719K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.0% | 3,885 | 3,693 | $640K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.1% | 12,819 | 11,951 | $399K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.8% | 7,733 | 6,932 | $360K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.7% | 6,062 | 5,434 | $346K |
| 71045 | Radiologic examination, chest; single view | 2.5% | 9,401 | 8,861 | $326K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.1% | 4,160 | 3,810 | $269K |
96 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.0% | 11,558 | $260K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.6% | 3,073 | $204K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 29,081 | $189K |
| 80053 | Comprehensive metabolic panel | 1.4% | 25,553 | $184K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.3% | 6,640 | $171K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.1% | 4,245 | $138K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,639 | $98K |
| 84484 | <1% | 10,227 | $89K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,865 | $86K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 356 | $75K |
| 83880 | <1% | 3,110 | $71K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,708 | $70K |
| 87631 | <1% | 830 | $70K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,721 | $68K |
| 81025 | <1% | 7,294 | $59K | |
| 83735 | <1% | 10,079 | $57K | |
| 83690 | <1% | 6,681 | $43K | |
| 81001 | <1% | 13,789 | $41K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 779 | $37K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 521 | $36K |
| 87088 | <1% | 3,525 | $31K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,642 | $29K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 997 | $28K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 376 | $24K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 49 | $23K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,731 | $22K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 84 | $21K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 545 | $20K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 351 | $19K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,542 | $17K |
| J3490 | Unclassified drugs | <1% | 3,207 | $16K |
| 85610 | <1% | 5,484 | $15K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 643 | $15K |
| 82962 | <1% | 5,790 | $13K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 313 | $12K |
| 87040 | <1% | 838 | $10K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,535 | $10K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 267 | $8K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,027 | $8K |
| 81003 | <1% | 2,874 | $7K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 129 | $7K |
| 83605 | <1% | 736 | $7K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 204 | $7K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 24 | $6K |
| 82728 | <1% | 610 | $6K | |
| 87430 | <1% | 377 | $5K | |
| 84466 | <1% | 576 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,369 | $5K |
| 94664 | <1% | 172 | $4K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 173 | $4K |
| 74022 | <1% | 69 | $4K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 58 | $3K |
| 97161 | <1% | 116 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,924 | $3K |
| 83540 | <1% | 576 | $3K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 14 | $3K |
| 82607 | <1% | 244 | $2K | |
| 82077 | <1% | 1,296 | $2K | |
| 85730 | <1% | 363 | $2K | |
| 84702 | <1% | 169 | $2K | |
| 87081 | <1% | 222 | $1K | |
| 87590 | <1% | 63 | $1K | |
| 87077 | <1% | 149 | $1K | |
| 85652 | <1% | 363 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 204 | $976.68 |
| 82746 | <1% | 101 | $926.58 | |
| 87807 | <1% | 60 | $699.72 | |
| 85379 | <1% | 90 | $664.01 | |
| 87070 | <1% | 73 | $654.53 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 138 | $652.98 |
| 86769 | <1% | 28 | $568.02 | |
| 87186 | <1% | 57 | $559.92 | |
| 82565 | <1% | 134 | $475.47 | |
| V2632 | Posterior chamber intraocular lens | <1% | 57 | $474.60 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 256 | $447.24 |
| 85027 | <1% | 67 | $419.81 | |
| 96376 | <1% | 14 | $411.91 | |
| 85007 | <1% | 138 | $351.32 | |
| 80076 | <1% | 44 | $309.69 | |
| 96367 | <1% | 13 | $251.64 | |
| 87015 | <1% | 31 | $241.28 | |
| 0352U | <1% | 12 | $237.86 | |
| 83921 | <1% | 12 | $211.34 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 38 | $111.02 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 16 | $108.84 |
| 82248 | <1% | 28 | $105.70 | |
| 99199 | Unlisted special service, procedure or report | <1% | 13 | $65.00 |
| 83615 | <1% | 15 | $63.24 | |
| G1010 | Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program | <1% | 798 | $47.77 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 26 | $45.92 |
| 84100 | <1% | 16 | $41.37 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 12 | $38.55 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 35 | $28.63 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 15 | $15.26 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 14 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHEINS, PATRICK (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| East Carolina Health - Heritage INC | Pinetops, NC | $1.27M |
| East Carolina Health - Heritage INC | Tarboro, NC | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.